Literature DB >> 29636882

Quantitative magnetic resonance imaging for diagnosis of intervertebral disc degeneration of the cervico-thoracic junction: a pilot study.

Zhihua Han1,2, Liang Gao3, Qinglei Shi4, Lei Chen1, Chun Chen1,5.   

Abstract

This study aimed to appraise two quantitative magnetic resonance imaging techniques, T2* imaging and diffusion-weighted imaging (DWI), for the diagnosis of the intervertebral disc degeneration of the cervico-thoracic junction. Influence of specific factors and diagnostic accuracy of both techniques were particularly explored. Sixty-one volunteers with neck and upper back pain were recruited and evaluated with both T2* imaging and DWI. The Pfirrmann grade, T2* relaxation time and apparent diffusion coefficient (ADC) value of each disc between C7 and T3 were recorded. Stratified analyses were performed for different anatomic levels, genders, age ranges and Pfirrmann grades. The diagnostic accuracy of both techniques was investigated using the receiver operating characteristic (ROC) curves. No statistically significant difference of either T2* relaxation time or ADC value was detected between males and females. Both parameters decreased with the increasing age and Pfirrmann grade. The ROC curves showed the higher sensitivity and specificity for T2* imaging than DWI to quantitatively identify the disc degeneration. Particularly, T2* imaging allowed for a quantitative distinguishing the normal, mild and moderate disc degeneration from the severe degeneration, which was unable to accomplish with DWI. In conclusion, we demonstrated that T2* imaging possess a better accuracy than DWI to quantitatively diagnose the intervertebral disc degeneration at the cervico-thoracic junction.

Entities:  

Keywords:  Quantitative MRI; cervico-thoracic junction; intervertebral disc degeneration

Year:  2018        PMID: 29636882      PMCID: PMC5883133     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  42 in total

1.  Composite motion in cervical disc segments.

Authors:  N Milne
Journal:  Clin Biomech (Bristol, Avon)       Date:  1993-07       Impact factor: 2.063

2.  MR imaging assessment of lumbar intervertebral disk degeneration and age-related changes: apparent diffusion coefficient versus T2 quantitation.

Authors:  G Niu; J Yang; R Wang; S Dang; E X Wu; Y Guo
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

3.  Injectable microcryogels reinforced alginate encapsulation of mesenchymal stromal cells for leak-proof delivery and alleviation of canine disc degeneration.

Authors:  Yang Zeng; Chun Chen; Wei Liu; Qinyouen Fu; Zhihua Han; Yaqian Li; Siyu Feng; Xiaokang Li; Chunxiao Qi; Jianhong Wu; Deli Wang; Christopher Corbett; Barbara P Chan; Dike Ruan; Yanan Du
Journal:  Biomaterials       Date:  2015-05-15       Impact factor: 12.479

4.  Upper thoracic-spine disc degeneration in patients with cervical pain.

Authors:  Estanislao Arana; Luis Martí-Bonmatí; Enrique Mollá; Salvador Costa
Journal:  Skeletal Radiol       Date:  2003-10-22       Impact factor: 2.199

5.  Disc degeneration assessed by quantitative T2* (T2 star) correlated with functional lumbar mechanics.

Authors:  Arin M Ellingson; Hitesh Mehta; David W Polly; Jutta Ellermann; David J Nuckley
Journal:  Spine (Phila Pa 1976)       Date:  2013-11-15       Impact factor: 3.468

6.  Assessment of apparent diffusion coefficient in lumbar intervertebral disc degeneration.

Authors:  Wei Zhang; Xiaohui Ma; Yan Wang; Jian Zhao; Xujing Zhang; Yu Gao; Shiling Li
Journal:  Eur Spine J       Date:  2014-04-06       Impact factor: 3.134

7.  Effect of coculturing canine notochordal, nucleus pulposus and mesenchymal stromal cells for intervertebral disc regeneration.

Authors:  Irene T M Arkesteijn; Lucas A Smolders; Sandra Spillekom; Frank M Riemers; Esther Potier; Björn P Meij; Keita Ito; Marianna A Tryfonidou
Journal:  Arthritis Res Ther       Date:  2015-03-14       Impact factor: 5.156

Review 8.  Cell-Based Therapies Used to Treat Lumbar Degenerative Disc Disease: A Systematic Review of Animal Studies and Human Clinical Trials.

Authors:  David Oehme; Tony Goldschlager; Peter Ghosh; Jeffrey V Rosenfeld; Graham Jenkin
Journal:  Stem Cells Int       Date:  2015-05-14       Impact factor: 5.443

9.  The effects of human Wharton's jelly cell transplantation on the intervertebral disc in a canine disc degeneration model.

Authors:  Yan Zhang; Hui Tao; Tao Gu; Mingyue Zhou; Zhiwei Jia; Gangqiang Jiang; Chun Chen; Zhihua Han; Cheng Xu; Deli Wang; Qing He; Dike Ruan
Journal:  Stem Cell Res Ther       Date:  2015-08-27       Impact factor: 6.832

10.  T2 relaxation time for intervertebral disc degeneration in patients with upper back pain: initial results on the clinical use of 3.0 Tesla MRI.

Authors:  Raoying Xie; Linhui Ruan; Lei Chen; Kai Zhou; Jiandong Yuan; Wei Ji; Guangjian Jing; Xiaojing Huang; Qinglei Shi; Chun Chen
Journal:  BMC Med Imaging       Date:  2017-01-31       Impact factor: 1.930

View more
  3 in total

1.  Intradiscal Injection of Autologous Discogenic Cells in Patients with Discectomy: A Prospective Clinical Study of Its Safety and Feasibility.

Authors:  Anwu Xuan; Dike Ruan; Chaofeng Wang; Qing He; Deli Wang; Lisheng Hou; Chao Zhang; Chao Li; Wei Ji; Tianyong Wen; Cheng Xu; Zhenbiao Zhu
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

2.  Feasibility of T2 Mapping and Magnetic Transfer Ratio for Diagnosis of Intervertebral Disc Degeneration at the Cervicothoracic Junction: A Pilot Study.

Authors:  Chao Zhang; Yuan Lin; Zhihua Han; Liang Gao; Ruipeng Guo; Qinglei Shi; Lei Chen; Chun Chen
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

3.  Comprehensive RNA expression profile of therapeutic adipose‑derived mesenchymal stem cells co‑cultured with degenerative nucleus pulposus cells.

Authors:  Zhihua Han; Qiugen Wang; Xiaoming Wu; Jiandong Wang; Liang Gao; Ruipeng Guo; Jianhong Wu
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.